Trial for the Diagnosis of Sarcoidosis (GRANULOMA)
Primary Purpose
Sarcoidosis
Status
Completed
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
EUS-FNA/EBUS-TBNA + BAL
EBB + TBLB + BAL
Sponsored by
About this trial
This is an interventional diagnostic trial for Sarcoidosis focused on measuring Sarcoidosis, Diagnosis, Non-caseating granulomas, BAL, EUS-FNA, EBUS-TBNA, TBLB
Eligibility Criteria
Inclusion Criteria:
- Patients with suspected pulmonary sarcoidosis stage I/ II
- Age > 18 years
- Both males and females
- Written informed consent is obtained.
Exclusion Criteria:
- Patients with obvious other organ involvement of sarcoidosis where a simple diagnostic biopsy to assess granulomas can be performed.
- Löfgren's syndrome
- Inability to undergo fiberbronchoscopy, EBUS or EUS (e.g. respiratory insufficiency, esophageal stenosis
- Contraindications for a lung or nodal biopsy (e.g. coagulopathy, thrombocytopenia)
- Pregnancy
- Inability to obtain informed consent
Sites / Locations
- Universitair Ziekenhuis Gent
- Gentofte Hospital Copenhagen
- Thoraxklinik Heidelberg
- Hospital Grosshansdorf
- Rijnstaete Ziekenhuis
- Radboud Universitair Medisch Centrum
- St. Catharina Ziekenhuis
- Medisch Centrum Haaglanden
- Pulmonary Department, Leiden University Medical Center
- Erasmus Medisch Centrum
- St. Franciscus Ziekenhuis
- University hospital Krakow, J.P. II
- Sokołowski Pulmonary Hospital
- Chelsea and Westminster hospital
- Royal Brompton Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
A
B
Arm Description
Endosonography arm
Conventional bronchoscopy arm
Outcomes
Primary Outcome Measures
The role of endosonography (EBUS/ EUS - FNA) in demonstrating non-caseating granulomas in comparison with conventional bronchoscopy (TBLB + EBB)
Secondary Outcome Measures
Assessment of complications of both the endosonography and conventional bronchoscopic workup
The additional value of BAL, in relation to endosonography and conventional bronchoscopy (TBLB + EBB), in diagnosing sarcoidosis
Assessment of patient preference for both the endosonographic and conventional bronchoscopic work-up.
Full Information
NCT ID
NCT00872612
First Posted
March 30, 2009
Last Updated
December 4, 2015
Sponsor
Leiden University Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT00872612
Brief Title
Trial for the Diagnosis of Sarcoidosis
Acronym
GRANULOMA
Official Title
Endosonography (EUS and EBUS) vs Conventional Bronchoscopy for the Diagnosis of Sarcoidosis: a Randomized Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2015
Overall Recruitment Status
Completed
Study Start Date
March 2009 (undefined)
Primary Completion Date
November 2011 (Actual)
Study Completion Date
May 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Leiden University Medical Center
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This randomized study investigates two different diagnostic strategies for patients with suspected pulmonary sarcoidosis stage I/II.
The objective is to assess the role of endosonography (EBUS/ EUS - FNA) in demonstrating non-caseating granulomas in comparison with conventional bronchoscopy (TBLB + EBB).
Also the researchers investigate the additional value of BAL, in relation to endosonography and conventional bronchoscopy (TBLB + EBB), in diagnosing sarcoidosis.
Thirdly the researchers aim to assess the rate of complications in both the endosonography and conventional bronchoscopic workup.
Detailed Description
Sarcoidosis is the most prevalent interstitial lung disease in Western-Europe and the US. The disease is most prevalent in young adults. To set the final diagnosis of sarcoidosis, the following parameters need to be present:
A clinical and radiological suspicion of sarcoidosis stage I/II.
A tissue diagnosis of disease-specific non-caseating granulomas.
Exclusion of possible alternative diagnoses as lung cancer or tuberculosis.
Nowadays, a bronchoscopy with lung biopsies is advised to set a tissue diagnosis of sarcoidosis. However, these biopsies are only diagnostic in 70% of the procedures and they are associated with a 3% risk of coughing up blood and a 4% risk of a lung collapse.
Since recently, a new diagnostic procedure has come available. This procedure, endo-sonography, makes it possible to biopsy lymph nodes in the chest under direct visualization and has a diagnostic accuracy of 85%. The associated risk of complications appears to be small (<1%)
We consider the current standard for the diagnostics of sarcoidosis to be outdated, considering the clinical availability of endo-sonography. We expect that endo-sonography is more frequent diagnostic for a tissue diagnosis of sarcoidosis.
Also we hypothesize that this technique is safer and more preferred by patients.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sarcoidosis
Keywords
Sarcoidosis, Diagnosis, Non-caseating granulomas, BAL, EUS-FNA, EBUS-TBNA, TBLB
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
304 (Actual)
8. Arms, Groups, and Interventions
Arm Title
A
Arm Type
Experimental
Arm Description
Endosonography arm
Arm Title
B
Arm Type
Active Comparator
Arm Description
Conventional bronchoscopy arm
Intervention Type
Procedure
Intervention Name(s)
EUS-FNA/EBUS-TBNA + BAL
Intervention Description
EUS-FNA = Endoscopic Ultrasound guided fine needle aspiration of mediastinal lymph nodes.
EBUS-TBNA = Endobronchial Ultrasound guided transbronchial needle aspiration of mediastinal and hilar lymph nodes.
BAL = bronchoalveolar lavage
Intervention Type
Procedure
Intervention Name(s)
EBB + TBLB + BAL
Intervention Description
EBB = Endobronchial biopsy TBLB = Transbronchial biopsy BAL = Bronchoalveolar lavage
Primary Outcome Measure Information:
Title
The role of endosonography (EBUS/ EUS - FNA) in demonstrating non-caseating granulomas in comparison with conventional bronchoscopy (TBLB + EBB)
Time Frame
within a week
Secondary Outcome Measure Information:
Title
Assessment of complications of both the endosonography and conventional bronchoscopic workup
Time Frame
within 30 days
Title
The additional value of BAL, in relation to endosonography and conventional bronchoscopy (TBLB + EBB), in diagnosing sarcoidosis
Time Frame
2 weeks
Title
Assessment of patient preference for both the endosonographic and conventional bronchoscopic work-up.
Time Frame
within a week
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with suspected pulmonary sarcoidosis stage I/ II
Age > 18 years
Both males and females
Written informed consent is obtained.
Exclusion Criteria:
Patients with obvious other organ involvement of sarcoidosis where a simple diagnostic biopsy to assess granulomas can be performed.
Löfgren's syndrome
Inability to undergo fiberbronchoscopy, EBUS or EUS (e.g. respiratory insufficiency, esophageal stenosis
Contraindications for a lung or nodal biopsy (e.g. coagulopathy, thrombocytopenia)
Pregnancy
Inability to obtain informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
M B von Bartheld, MSc
Organizational Affiliation
Pulmonary Department, Leiden University Medical Center
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
J T Annema, MD PhD
Organizational Affiliation
Pulmonary Department, Leiden University Medical Center
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
K F Rabe, MD PhD
Organizational Affiliation
Pulmonary Department, Leiden University Medical Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Universitair Ziekenhuis Gent
City
Gent
ZIP/Postal Code
9000
Country
Belgium
Facility Name
Gentofte Hospital Copenhagen
City
Hellerup
State/Province
Copenhagen
ZIP/Postal Code
2900
Country
Denmark
Facility Name
Thoraxklinik Heidelberg
City
Heidelberg
State/Province
Baden-Württemberg
ZIP/Postal Code
69126
Country
Germany
Facility Name
Hospital Grosshansdorf
City
Grosshansdorf
State/Province
Schleswig-Holstein
ZIP/Postal Code
22927
Country
Germany
Facility Name
Rijnstaete Ziekenhuis
City
Arnhem
State/Province
Gelderland
Country
Netherlands
Facility Name
Radboud Universitair Medisch Centrum
City
Nijmegen
State/Province
Gelderland
Country
Netherlands
Facility Name
St. Catharina Ziekenhuis
City
Eindhoven
State/Province
Noord-Brabant
Country
Netherlands
Facility Name
Medisch Centrum Haaglanden
City
Den Haag
State/Province
Zuid-Holland
Country
Netherlands
Facility Name
Pulmonary Department, Leiden University Medical Center
City
Leiden
State/Province
Zuid-Holland
ZIP/Postal Code
2300 RC
Country
Netherlands
Facility Name
Erasmus Medisch Centrum
City
Rotterdam
State/Province
Zuid-Holland
ZIP/Postal Code
3015 CE
Country
Netherlands
Facility Name
St. Franciscus Ziekenhuis
City
Rotterdam
State/Province
Zuid-Holland
Country
Netherlands
Facility Name
University hospital Krakow, J.P. II
City
Krakow
Country
Poland
Facility Name
Sokołowski Pulmonary Hospital
City
Zakopane
Country
Poland
Facility Name
Chelsea and Westminster hospital
City
London
ZIP/Postal Code
SW10 9NH
Country
United Kingdom
Facility Name
Royal Brompton Hospital
City
London
Country
United Kingdom
12. IPD Sharing Statement
Citations:
PubMed Identifier
10573213
Citation
Costabel U, Hunninghake GW. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 1999 Oct;14(4):735-7. doi: 10.1034/j.1399-3003.1999.14d02.x. No abstract available.
Results Reference
background
PubMed Identifier
18032765
Citation
Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007 Nov 22;357(21):2153-65. doi: 10.1056/NEJMra071714. No abstract available.
Results Reference
background
PubMed Identifier
8339618
Citation
Winterbauer RH, Lammert J, Selland M, Wu R, Corley D, Springmeyer SC. Bronchoalveolar lavage cell populations in the diagnosis of sarcoidosis. Chest. 1993 Aug;104(2):352-61. doi: 10.1378/chest.104.2.352.
Results Reference
background
PubMed Identifier
9493649
Citation
Kantrow SP, Meyer KC, Kidd P, Raghu G. The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J. 1997 Dec;10(12):2716-21. doi: 10.1183/09031936.97.10122716.
Results Reference
background
PubMed Identifier
15738281
Citation
Annema JT, Veselic M, Rabe KF. Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of sarcoidosis. Eur Respir J. 2005 Mar;25(3):405-9. doi: 10.1183/09031936.05.00098404.
Results Reference
background
PubMed Identifier
17890467
Citation
Garwood S, Judson MA, Silvestri G, Hoda R, Fraig M, Doelken P. Endobronchial ultrasound for the diagnosis of pulmonary sarcoidosis. Chest. 2007 Oct;132(4):1298-304. doi: 10.1378/chest.07-0998. Epub 2007 Sep 21.
Results Reference
background
PubMed Identifier
23780458
Citation
von Bartheld MB, Dekkers OM, Szlubowski A, Eberhardt R, Herth FJ, in 't Veen JC, de Jong YP, van der Heijden EH, Tournoy KG, Claussen M, van den Blink B, Shah PL, Zoumot Z, Clementsen P, Porsbjerg C, Mauad T, Bernardi FD, van Zwet EW, Rabe KF, Annema JT. Endosonography vs conventional bronchoscopy for the diagnosis of sarcoidosis: the GRANULOMA randomized clinical trial. JAMA. 2013 Jun 19;309(23):2457-64. doi: 10.1001/jama.2013.5823.
Results Reference
derived
Learn more about this trial
Trial for the Diagnosis of Sarcoidosis
We'll reach out to this number within 24 hrs